share_log

Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta

Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta

EQONEX 有限公司的證券除牌;斯科普生物製藥股份有限公司;峰值生物製藥股份有限公司;Tricida,股份有限公司;Arbor Rapha 資本生物控股股份有限公司;卡利瑟拉生物科學股份有限公司;聯合醫療產品有限公司;以及 Meta
GlobeNewswire ·  2023/03/01 16:17

NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on November 30, 2022, and have not traded on Nasdaq since that time.

紐約,2023 年 3 月 1 日(環球美通社)-納斯達克股票市場今天宣布將撤銷 EQONEX 有限公司的普通股。EQONEX 有限公司普通股於 2022 年 11 月 30 日暫停交易,自那時起未在納斯達克上市交易。

Nasdaq also announced today that it will delist the common stock of Scopus BioPharma Inc. Scopus BioPharma Inc. common stock was suspended on December 19, 2022, and has not traded on Nasdaq since that time.

納斯達克今天還宣佈,將取消 Scopus 生物製藥股份有限公司普通股於 2022 年 12 月 19 日停牌,並且從那時起就沒有在納斯達克交易。

Nasdaq also announced today that it will delist the common stock and warrant of Peak Bio, Inc. Peak Bio, Inc.'s securities were suspended on January 10, 2023, and have not traded on Nasdaq since that time.

納斯達克今天還宣布,它將取消 Peak Bio 公司 Peak Bio 公司的普通股和保證證。的證券於 2023 年 1 月 10 日暫停,並且自那時起尚未在納斯達克交易。

Nasdaq also announced today that it will delist the common stock of Statera Biopharma, Inc. Statera Biopharma, Inc. common stock was suspended on January 12, 2023, and has not traded on Nasdaq since that time.

納斯達克今天還宣布,將取消斯泰拉生物製藥公司普通股股份有限公司普通股於 2023 年 1 月 12 日暫停銷售,並且自那時以來一直沒有在納斯達克交易。

Nasdaq also announced today that it will delist the common stock of Tricida, Inc. Tricida, Inc. common stock was suspended on January 24, 2023, and has not traded on Nasdaq since that time.

納斯達克今天還宣布,將取消 Tricida 股份有限公司普通股於 2023 年 1 月 24 日停牌,並且從那時起就沒有在納斯達克上市交易。

Nasdaq also announced today that it will delist the Class A Common Stock, units, and warrants of Arbor Rapha Capital Bioholdings Corp. I. Arbor Rapha Capital Bioholdings Corp. I's securities were suspended on January 24, 2023, and have not traded on Nasdaq since that time.

納斯達克今天也宣佈,將取消 ARBOR Rapha 資本生物控股股份有限公司 ARBOR Rapha Capital 生物控股股份有限公司 I 的 A 類普通股、單位和認股權證於 2023 年 1 月 24 日被停牌,並且從那時起就沒有在納斯達克上市交易。

Nasdaq also announced today that it will delist the common stock of Calithera Biosciences, Inc. Calithera Biosciences, Inc.'s common stock was suspended on February 2, 2023, and has not traded on Nasdaq since that time.

納斯達克今天還宣布,它將取消卡利瑟拉生物科學公司卡利瑟拉生物科學公司的普通股。」普通股於 2023 年 2 月 2 日暫停交易,自那時起一直沒有在納斯達克交易。

Nasdaq also announced today that it will delist the common stock of Waitr Holdings Inc. Waitr Holdings Inc.'s common stock was suspended on February 2, 2023, and has not traded on Nasdaq since that time.

納斯達克今天還宣布,將取消 Waitr 控股有限公司 Waitr 控股有限公司的普通股。普通股於 2023 年 2 月 2 日暫停交易,自那時起一直沒有在納斯達克交易。

Nasdaq also announced today that it will delist the common stock of Allied Healthcare Products, Inc. Allied Healthcare Products, Inc.'s common stock was suspended on February 3, 2023, and has not traded on Nasdaq since that time.

納斯達克(Nasdaq)今天還宣布,將取消聯合醫療產品公司聯合醫療產品公司的普通股份有限公司。」普通股於 2023 年 2 月 3 日暫停交易,並且自那時以來一直沒有在納斯達克交易。

Nasdaq also announced today that it will delist the common stock of Metacrine, Inc. Metacrine, Inc.'s common stock was suspended on February 9, 2023, and has not traded on Nasdaq since that time.

納斯達克指數今天還宣布,它將取消 Metacrine 公司 Metacrine 公司的普通股。普通股於 2023 年 2 月 9 日暫停交易,並且自那時以來一直沒有在納斯達克交易。

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies' securities are trading on another venue, please review the companies' public filings or contact the company directly.

納斯達克(Nasdaq)將向美國證券交易委員會提交 25 表格以完成交易。除牌日期在 25 表格提交後十天生效。有關公司的新聞和其他信息,包括除牌基礎以及該公司的證券是否在另一個地點買賣,請查看公司的公開文件或直接與該公司聯繫。

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at  Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.

有關納斯達克證券市場的更多信息,請訪問納斯達克網站納斯達克管理證券除牌規則的納斯達克網站,可以在納斯達克網站上找到納斯達克規則 5800 系列。https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series

-NDAQO- 

-恩达-


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論